Correction to: Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial

被引：0
|
作者：
Bee Kim Tan
Siew Siang Chua
Li-Chia Chen
Kian Meng Chang
Sharmini Balashanker
Ping Chong Bee
机构：
[1] Jalan Universiti,Department of Medicine, Faculty of Medicine, University of Malaya
[2] Taylor’s University,School of Pharmacy, Faculty of Health and Medical Sciences
[3] University of Manchester,Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health
[4] Manchester Academic Health Science Centre,Department of Hematology
[5] Ampang Hospital,School of Pharmacy
[6] Ministry of Health Malaysia,undefined
[7] University of Nottingham Malaysia Campus,undefined
来源：
Supportive Care in Cancer | 2020年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Revised Funding Information.
引用
收藏
页码：3249 / 3249
相关论文
共 50 条
  • [31] The effectiveness of tyrosine kinase inhibitors and molecular response in newly diagnosed patients of chronic myeloid leukaemia
    Fareed, N.
    Somroo, N. M.
    Quraishy, M. S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 210 - 211
  • [32] Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
    Tinsley, Sara M.
    JOURNAL OF CLINICAL NURSING, 2010, 19 (9-10) : 1207 - 1218
  • [33] Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
    Santos, Fabio P. S.
    Kantarjian, Hagop
    Fava, Carmen
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Wierda, William
    Thomas, Deborah
    Shan, Jianquin
    Cortes, Jorge
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (03) : 303 - 312
  • [34] Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors
    Kondapalli, Lavanya
    Worth, Sarah
    Hawi, Riem
    Vachhani, Pankit
    Arora, Garima
    Bhatia, Ravi
    Lenneman, Carrie G.
    VASCULAR MEDICINE, 2020, 25 (03) : 246 - 254
  • [35] Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors Treatment
    Wieczorek, Agnieszka
    Uharek, Lutz
    BIOMARKER INSIGHTS, 2015, 10 : 49 - 54
  • [36] Adherence to tyrosine kinase inhibitors among adult chronic myeloid leukemia patients in a Malaysia hospital
    Lee, P. M.
    Chang, C. T.
    Yusoff, Z. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 46 - 54
  • [37] Adherence to tyrosine kinase inhibitors among adult chronic myeloid leukemia patients in a Malaysia hospital
    P. M. Lee
    C. T. Chang
    Z. M. Yusoff
    International Journal of Clinical Pharmacy, 2021, 43 : 46 - 54
  • [38] PHARMACOECONOMIC STUDY OF THE INTERRUPTION OF TREATMENT WITH TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA. EXPERIENCE IN REAL CLINICAL PRACTICE
    Merchan, Munoz B.
    Nuevo, Lopez, I
    De Miguel, Llorente D.
    Gil, Perez A.
    Morales, Sanz M. D.
    Perez, Ortega A.
    Guillen, Garcia H.
    Mora, Argumanez M.
    Vazquez, Ramo A.
    Santos, Morales A. B.
    Golbano, Lopez N.
    Herrero, Martin S.
    Arbeteta, Juanis J.
    Subira, D.
    HAEMATOLOGICA, 2020, 105 : 153 - 154
  • [39] The role of stem cell transplantation in paediatric patients with chronic myeloid leukaemia in the era of tyrosine kinase inhibitors
    Suttorp, M.
    Tauer, J. T.
    von Neuhoff, N.
    Nowasz, C.
    Bradtke, J.
    Teigler-Schlegel, A.
    Thiede, C.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S52 - S52
  • [40] Side effects of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukaemia and the occurrence of depressive symptoms
    Gibek, Katarzyna
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (04): : 277 - 283
12345